Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Foghorn Therapeutics Inc.

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K/A10-KS-1/A
Assets       
Current assets:       
    Cash and cash equivalents  52.2101.192.815.0 
    Marketable securities  293.653.293.0  
    Prepaid expenses and other current assets  5.65.34.91.4 
        Total current assets  351.4459.6190.716.9 
Property and equipment, net  15.317.6   
Restricted cash  1.71.7   
Other assets  2.42.40.80.0 
Operating lease right-of-use assets  34.138.5   
    Total assets  404.9519.8255.622.3 
   
Liabilities and Stockholders’ Equity (Deficit)       
Current liabilities:       
    Accounts payable  5.43.83.73.4 
    Accrued expenses and other current liabilities  11.09.69.2  
    Operating lease liabilities  6.07.0   
    Deferred revenue  32.828.3   
        Total current liabilities  55.248.718.812.7 
Operating lease liabilities, net of current portion  45.551.3   
Deferred revenue, net of current portion  304.0322.7   
Other liabilities  0.00.1   
    Total liabilities  404.8422.9109.423.8 
   
Commitments and contingencies (Note 10)       
Stockholders’ equity (deficit):       
    Common stock  0.00.00.0  
    Additional paid-in capital  377.2361.1309.16.1 
    Accumulated other comprehensive loss  -4.00.00.0  
    Accumulated deficit  -373.1-264.3-162.9-94.1 
        Total stockholders’ equity (deficit)  0.196.9146.2-88.0 
    Total liabilities and stockholders’ equity (deficit)  404.9519.8255.622.3 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy